SEC 13F Intelligence

Orbimed Advisors LLC / SYK

Orbimed Advisors LLC’s Stryker Corporation Position

Does Orbimed Advisors LLC own Stryker Corporation (SYK)? Yes182.5K shares worth $60M (+1.19% of its 13F portfolio) as of Q1 2026, down from 325.0K shares the prior filed quarter.

Position Value
$60M
Q1 2026
Shares
182.5K
% of Portfolio
+1.19%
Quarters Held
27
currently held

Position History SYK

Reported value by quarter
Q4 ’18: $20MQ4 ’18Q1 ’19: $11MQ2 ’19: $11MQ1 ’20: $62MQ3 ’20: $49MQ3 ’20Q4 ’20: $58MQ1 ’21: $82MQ2 ’21: $88MQ3 ’21: $89MQ3 ’21Q4 ’21: $124MQ1 ’22: $122MQ2 ’22: $88MQ3 ’22: $86MQ3 ’22Q4 ’22: $118MQ1 ’23: $105MQ2 ’23: $83MQ3 ’23: $74MQ3 ’23Q4 ’23: $81MQ1 ’24: $96MQ2 ’24: $92MQ3 ’24: $124MQ3 ’24Q4 ’24: $124MQ1 ’25: $134MQ2 ’25: $142MQ3 ’25: $133MQ3 ’25Q4 ’25: $114MQ1 ’26: $60Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026182.5K$60M+1.19%
Q4 2025325.0K$114M+2.33%
Q3 2025359.2K$133M+3.12%
Q2 2025359.2K$142M+3.55%
Q1 2025359.2K$134M+3.19%
Q4 2024344.4K$124M+2.55%
Q3 2024344.4K$124M+2.26%
Q2 2024269.0K$92M+1.81%
Q1 2024269.0K$96M+1.76%
Q4 2023269.0K$81M+1.61%
Q3 2023269.0K$74M+1.56%
Q2 2023271.4K$83M+1.50%
Q1 2023367.6K$105M+2.06%
Q4 2022481.0K$118M+2.25%
Q3 2022423.1K$86M+1.59%
Q2 2022441.1K$88M+1.59%
Q1 2022457.1K$122M+1.98%
Q4 2021465.3K$124M+1.60%
Q3 2021337.4K$89M+0.98%
Q2 2021337.4K$88M+0.89%
Q1 2021337.4K$82M+0.77%
Q4 2020235.0K$58M+0.50%
Q3 2020235.0K$49M+0.62%
Q1 2020371.1K$62M+1.04%
Q2 201954.0K$11M+0.17%
Q1 201954.0K$11M+0.17%
Q4 2018130.2K$20M+0.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of SYK.